557 related articles for article (PubMed ID: 15492183)
1. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Int J Dermatol; 2005 Oct; 44(10):841-5. PubMed ID: 16207186
[TBL] [Abstract][Full Text] [Related]
3. Melanocyte-keratinocyte cell transplantation for stable vitiligo.
Mulekar SV
Int J Dermatol; 2003 Feb; 42(2):132-6. PubMed ID: 12709002
[TBL] [Abstract][Full Text] [Related]
4. Childhood vitiligo: a long-term study of localized vitiligo treated by noncultured cellular grafting.
Mulekar SV; Al Eisa A; Delvi MB; Al Issa A; Al Saeed AH
Pediatr Dermatol; 2010; 27(2):132-6. PubMed ID: 19804496
[TBL] [Abstract][Full Text] [Related]
5. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
[TBL] [Abstract][Full Text] [Related]
6. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting.
Mulekar SV; Al Issa A; Al Eisa A
Dermatol Surg; 2009 Jan; 35(1):66-71. PubMed ID: 19076191
[TBL] [Abstract][Full Text] [Related]
7. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
[TBL] [Abstract][Full Text] [Related]
8. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
van Geel N; Ongenae K; De Mil M; Haeghen YV; Vervaet C; Naeyaert JM
Arch Dermatol; 2004 Oct; 140(10):1203-8. PubMed ID: 15492182
[TBL] [Abstract][Full Text] [Related]
9. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.
El-Zawahry BM; Zaki NS; Bassiouny DA; Sobhi RM; Zaghloul A; Khorshied MM; Gouda HM
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):215-20. PubMed ID: 20569286
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity.
Fongers A; Wolkerstorfer A; Nieuweboer-Krobotova L; Krawczyk P; Tóth GG; van der Veen JP
Br J Dermatol; 2009 Nov; 161(5):1105-11. PubMed ID: 19673878
[TBL] [Abstract][Full Text] [Related]
11. Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents.
Sahni K; Parsad D; Kanwar AJ
Clin Exp Dermatol; 2011 Aug; 36(6):607-12. PubMed ID: 21507039
[TBL] [Abstract][Full Text] [Related]
12. Treatment of vitiligo lesions by ReCell vs. conventional melanocyte-keratinocyte transplantation: a pilot study.
Mulekar SV; Ghwish B; Al Issa A; Al Eisa A
Br J Dermatol; 2008 Jan; 158(1):45-9. PubMed ID: 17927795
[TBL] [Abstract][Full Text] [Related]
13. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632
[TBL] [Abstract][Full Text] [Related]
14. Treatment of stable vitiligo by ReCell system.
Cervelli V; De Angelis B; Balzani A; Colicchia G; Spallone D; Grimaldi M
Acta Dermatovenerol Croat; 2009; 17(4):273-8. PubMed ID: 20021980
[TBL] [Abstract][Full Text] [Related]
15. Melanocyte transplantation for the treatment of vitiligo: effects of different surgical techniques.
Issa CM; Rehder J; Taube MB
Eur J Dermatol; 2003; 13(1):34-9. PubMed ID: 12609779
[TBL] [Abstract][Full Text] [Related]
16. Treatment of vitiligo with a melanocyte-keratinocyte cell suspension versus dermabrasion only: a pilot study with a 12-month follow up.
Vázquez-Martínez OT; Martínez-Rodríguez HG; Velásquez-Arenas L; Baños-González D; Ortíz-López R; Padilla-Rivas G; Welsh O; Ocampo-Candiani J
J Drugs Dermatol; 2011 Sep; 10(9):1032-6. PubMed ID: 22052273
[TBL] [Abstract][Full Text] [Related]
17. Autologous melanocyte transfer via epidermal grafts for lip vitiligo.
Gupta S; Goel A; Kanwar AJ; Kumar B
Int J Dermatol; 2006 Jun; 45(6):747-50. PubMed ID: 16796641
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo.
Ramos MG; Ramos DG; Ramos CG
An Bras Dermatol; 2017; 92(3):312-318. PubMed ID: 29186240
[TBL] [Abstract][Full Text] [Related]
20. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]